Americafirst Capital Management’s Pfizer PFE Stock Holding History

Americafirst Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$127K	Buy	+3,760	New	+$121K	0.17%	164
2017 Q1	–	Sell	-3,221	Closed	-$99.3K	–	221
2016 Q4	$99.3K	Sell	3,221 -53,012	-94%	-$1.62M	0.1%	171
2016 Q3	$1.81M	Sell	56,233 -9,511	-14%	-$318K	1.5%	8
2016 Q2	$2.2M	Buy	65,744 +100	+0.2%	+$3.19K	1.42%	16
2016 Q1	$1.85M	Buy	+65,644	New	+$1.88M	1.16%	22
2014 Q4	–	Sell	-78,055	Closed	-$2.19B	–	270
2014 Q3	$2.19B	Buy	+78,055	New	+$2.19M	1.08%	16

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Americafirst Capital Management's PFE Position: Q3 2017 in Review

Americafirst Capital Management opened a new position in Pfizer (PFE) in Q3 2017: 3,760 shares worth $127K. The stake represents 0.17% of the portfolio and ranks #164 among its holdings. This is a return to the name: Americafirst Capital Management previously reported a position in PFE as recently as Q4 2016.

Americafirst Capital Management first reported a position in PFE in Q3 2014 and has held it in 6 quarters since. The position peaked at $2.19B in Q3 2014. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Americafirst Capital Management held 3,760 shares of Pfizer worth $127K as of Q3 2017.
Pfizer was a new Americafirst Capital Management position in Q3 2017.
Pfizer made up 0.17% of Americafirst Capital Management's portfolio in Q3 2017, its #164 holding.
Americafirst Capital Management first reported a position in Pfizer in Q3 2014 and has held it in 6 quarters since.
Americafirst Capital Management's Pfizer position peaked at $2.19B in Q3 2014.
2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Americafirst Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.